Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000565292 | SCV000674732 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-12-20 | criteria provided, single submitter | clinical testing | The c.78_80dupGCC variant (also known as p.P29dup), located in coding exon 1 of the RB1 gene, results from an in-frame duplication of GCC at nucleotide positions 78 to 80. This results in the duplication of an extra proline residue between codons 29 and 30. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be neutral by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV000820387 | SCV000961097 | uncertain significance | Retinoblastoma | 2023-11-13 | criteria provided, single submitter | clinical testing | This variant, c.78_80dup, results in the insertion of 1 amino acid(s) of the RB1 protein (p.Pro29dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs775630214, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with RB1-related conditions. ClinVar contains an entry for this variant (Variation ID: 486294). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |